Increasing awareness of Nasal Drug Improves Demand for Nasal Drug Delivery Systems
Nasal Drug Delivery Systems The nasal medication delivery method is a non-invasive alternative to invasive administrations that allows for direct access to the systemic circulation. Intranasal medication delivery is the most frequent and recommended method for treating allergic and non-allergic rhinitis, discomfort, acute migraine therapy, and nasal congestion caused by sinusitis, the common cold, or rhinitis. Nasal medication delivery is most commonly employed when a quick start of action is required, or to reach a place where conventional routes of administration have failed. For needle-free immunisation and systemic medication administration, nasal drug delivery is also the recommended approach. Inhalers, droppers, spray pumps, nebulizers, and atomizers can all be used to provide liquid nasal solutions. The global nasal drug delivery systems market size is estimated to be valued at US$ 48.1 billion in 2018 and is expected to witness a CAGR of 6.3% over the forecast period (201